European Commission examines Falsified Medicines Directive

European Comission Falsified Medicines

European Commission examines Falsified Medicines Directive

The European Commission has released a report on how it applies Directive 2011/62/EU, which combats falsified medicines and strengthens the supervision of the medicines supply chain in the EU. Delegated Regulation (EU) 2016/161, in force since February 9, 2019, complements this directive with rules for safety features on packaging. Read more here

If you need more information on regulatory issues, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

I want to speak to a Specialist

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.

I want to speak to a Specialist